FDA approves Moderna's mRNA influenza vaccine for adults 50 and older
Moderna (NASDAQ: MRNA) announced that the U.S. Food and Drug Administration has approved its mFLUSIVA (mRNA-1010) influenza vaccine for adults ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)